Beryl Drugs Share Price

Beryl Drugs

CMP as on23-May-22 15:15

₹ 8.69
-0.45 -4.92%

Open

₹ 9.14

Turnover (lac)

Prev. Close

₹ 9.14

Day's Vol (shares)

₹ 496

Day's Range

₹ 8.69
₹ 9.14

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Feb-2022 - -
BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve consider and approve the unaudited financial results for the quarter ended 31st December 2021 OUTCOME OF 38TH BOARD MEETING UNAUDITED FINANCIAL REULTS FOR THE QUARTER ENDED 31ST DECEMBER, 2021 (As Per BSE Announcement dated on 11.02.2022)
Board Meeting - 03-Nov-2021 - -
Quarterly Results OUTCOME OF BOARD MEETING (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 25-Aug-2021 - -
Inter alia, to consider and approve : 1. to approve the Board report of the Company; 2. to fix the date and approve notice of the 28th Annual General Meeting of the Company; 3. to fix the dates of the Annual Book Closure of the Company for the 28th Annual General Meeting; 4. fix the Cut-off Date and Remote E-voting period for the Ensuing AGM; 5. to appoint Scrutinizer for the purpose of remote e-voting and voting at 28th Annual General 6. to Authorize Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company 7. to recommend the increase in remuneration of Mr. Sanjay Sethi (DIN: 00090277), Managing Director of the Company 1. Approved the Board report of the Company; 2. Fixation of the date and approve notice of the 28th Annual General Meeting of the Company; 3. Fixation of the dates of the Annual Book Closure of the Company for the 28th Annual General Meeting; 4. Fixation of the Cut-off Date and Remote E-voting period for the Ensuing AGM; 5. Appointment of the Scrutinizer for the purpose of remote e-voting and voting at 28th Annual General meeting 6. Authorized Directors of the Company to authenticate and file forms under Companies Act, 2013 on behalf of the Company 7. Considered and approved the increase in remuneration of Mr. Sanjay Sethi (DIN: 00090277), Managing Director of the Company (As Per BSE Announcement Dated 03.09.2021)
Board Meeting - 05-Aug-2021 - -
Quarterly Results Outcome of Board Meeting (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 22-Jun-2021 - -
BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve 1. Consider and adopt the audited accounts for the year ended March 31, 2021 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, 2. Take a note of Audited Results to be published in terms of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP-1. 4. To consider and approve the appointment of Abhay Bhandari & Associates, Chartered Accountants as Internal Auditor of the Company for the Financial Year 2021-2022. 5. To consider and approve the appointment of Ashish Karodia & Company, Practicing Company Secretary as Secretarial Auditor of the Company for the year 2021-2022 6. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2021-2022 Outcome of board meeting held on 30th June, 2021 (As Per BSE Announcement dated on 30.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity